Mycophenolic Acid Tablet, Delayed Release
Product Images NDC 70436-173

7 FDA label images from Slate Run Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Mycophenolic Acid (NDC 70436-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ink-01-slate-run (Ink 01 Slate Run)

Ink-01-slate-run (Ink 01 Slate Run)
Mycophenolic Acid 360 mg delayed-release tablets packaging label from Slate Run Pharmaceuticals, LLC. The label highlights the proprietary name, dosage strength of 360 mg, and dosage form as oral tablets. The design features a color scheme with teal, light blue, and gray areas, and includes prominent vertical bars on the left side.*
FDA Label Image

Ink-02-slate-run (Ink 02 Slate Run)

Ink-02-slate-run (Ink 02 Slate Run)
Mycophenolic Acid 180 mg delayed-release tablets packaging by Slate Run Pharmaceuticals, LLC. The image shows a single tablet blister card with five tablets visible. The packaging includes product name and strength along with the labeler information.*
FDA Label Image

Chemical Structure-slate-run (Chemical Structure Slate Run)

Chemical Structure-slate-run (Chemical Structure Slate Run)
Chemical structure of mycophenolic acid, showing its molecular components and arrangement, including rings, hydroxyl groups, and a sodium salt moiety, consistent with the active ingredient in Mycophenolic Acid tablets.*
FDA Label Image

Ink-03-slate-run (Ink 03 Slate Run)

Ink-03-slate-run (Ink 03 Slate Run)
Mycophenolic Acid 180 mg delayed-release tablets packaging by Slate Run Pharmaceuticals, LLC. The label displays the product name prominently with strength indicated. The tablet count and detailed labeling information including dosage form and route are visible on the bottle. The container has a white body with a white child-resistant cap.*
FDA Label Image

Ink-04-slate-run (Ink 04 Slate Run)

Ink-04-slate-run (Ink 04 Slate Run)
Mycophenolic Acid 180 mg delayed-release tablets carton by Slate Run Pharmaceuticals, LLC. The packaging is primarily white and blue, displaying the product name, strength, dosage form, and labeler information clearly. The carton includes regulatory and identification details with a barcode on one side.*
FDA Label Image

180mg-120ct-slate-run (180mg 120ct Slate Run)

180mg-120ct-slate-run (180mg 120ct Slate Run)
Packaging label for Mycophenolic Acid Delayed-Release Tablets, USP 180 mg, oral tablets supplied in a bottle of 120 count by Slate Run Pharmaceuticals, LLC. Label includes directions to dispense the Medication Guide, storage instructions, child-resistant packaging information, and manufacturer's details from Yichang Humanwell Oral Solid Dosage Plant, China.*
FDA Label Image

360mg-120ct-slate-run (360mg 120ct Slate Run)

360mg-120ct-slate-run (360mg 120ct Slate Run)
Label for Mycophenolic Acid Delayed-Release Tablets, USP, 360 mg strength, oral dosage form. The label indicates 120 tablets per container. It includes storage instructions, child safety warnings, and manufacturer information from Slate Run Pharmaceuticals, LLC. The label also instructs pharmacists to dispense an accompanying Medication Guide to patients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.